Wednesday - September 3, 2025
Alzheimer's Association Welcomes FDA Action Approving Leqembi Weekly Subcutaneous Maintenance Dosing
August 29, 2025
CHICAGO, Illinois, Aug. 29 [Category: Health Care] -- The Alzheimer's Association posted the following news release:

* * *

Alzheimer's Association Welcomes FDA Action Approving Leqembi Weekly Subcutaneous Maintenance Dosing

*

CHICAGO, August 29, 2025 -- The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) action to approve weekly subcutaneous maintenance dosing of Leqembi(r) (lecanemab, Eisai/ . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products